Danaher Corp.

NYSE:DHR   12:55:24 AM EDT
+4.31 (+1.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)197.87B
Current PE27.45
Forward PE 26.94
2yr Forward PE 24.47
See more stats
Estimates Current Quarter
Revenue$7.06 Billion
Adjusted EPS$2.27
See more estimates
10-Day MA$267.87
50-Day MA$266.25
200-Day MA$264.42
See more pivots

Danaher Corp. Stock, NYSE:DHR

2200 Pennsylvania Avenue NW, Suite 800 West, Washington, District of Columbia 20037-1701
United States of America
Phone: +1.202.828.0850
Number of Employees: 80000


Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment is composed of analytical instruments, reagents, consumables, software, and services that hospitals, physicians' offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.